Health Canada inspection
Astellas Pharma Inc.: Health Canada inspection of Dec 14, 2022
Health Canada · GMP · rating C
Key facts
| Establishment | Astellas Pharma Inc. |
|---|---|
| City | Takahagi-Shi |
| Province | Ibaraki |
| Country | Japan |
| Program | GMP |
| Start date | Dec 13, 2022 |
| End date | Dec 14, 2022 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.